Comparison of different promoters to improve AAV vectormediated gene therapy for neuronopathic Gaucher disease

dc.article.end-page1480en
dc.article.start-page1467en
dc.citation.doi10.1093/HMG/DDAE081en
dc.contributor.authorG Massaroen
dc.contributor.authorAmy Gearden
dc.contributor.authorH Nelvagalen
dc.contributor.authorK Goreen
dc.contributor.authorN Clemoen
dc.contributor.authorSimon Waddingtonen
dc.contributor.authorAhad Rahimen
dc.date.accessioned2024-10-19T13:34:22Z
dc.date.available2024-10-19T13:34:22Z
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn0964-6906en
dc.identifier.urihttps://hdl.handle.net/10539/41726
dc.journal.titleComparison of different promoters to improve AAV vectormediated gene therapy for neuronopathic Gaucher diseaseen
dc.journal.volume33en
dc.publisherOXFORD UNIV PRESSen
dc.titleComparison of different promoters to improve AAV vectormediated gene therapy for neuronopathic Gaucher diseaseen
dc.typeJournal Articleen
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Journal Article.pdf
Size:
1.98 MB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client